As it occurs for HERC1, also the HERC2 gene expression is profoundly reduced in CML patients at diagnosis, but it is restored to normal levels and with a relatively rapid kinetic upon disease remission. The gene discussed is HERC2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.